Anavex Life Sciences (AVXL) vs Eledon Pharmaceuticals (ELDN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 18, 2026.
Summary
Eledon Pharmaceuticals (ELDN) has outperformed Anavex Life Sciences (AVXL) over the past year, losing 38.1% versus a loss of 85.4%. Over five years, ELDN leads with a -58.1% price change compared with -92.7% for AVXL. Eledon Pharmaceuticals is the larger company by market cap ($173.1 million vs $121.4 million), about 1.4 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AVXL | ELDN |
|---|---|---|
| Share price | $1.31 | $2.13 |
| Market cap | $121.43M | $173.09M |
| 1-day change | -11.49% | -6.17% |
| YTD return | -63.20% | +41.06% |
| 1-year return | -85.41% | -38.08% |
| 5-year return | -92.66% | -58.07% |
| EPS (TTM) | $-0.14 | $-0.90 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Net income (latest FY) | $-46.38M | $-45.62M |
| 52-week high | $9.50 | $4.60 |
| 52-week low | $1.30 | $1.35 |
| Distance from 52-week high | -86.21% | -53.70% |
| Analyst consensus | none | none |
| Avg. price target upside | — | +322.54% |
| Average volume | 1.01M | 914.37K |
| Shares outstanding | 92.70M | 81.26M |
| Employees | 34 | 33 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ELDN has outperformed AVXL by 47.3 percentage points over the past year.
About Anavex Life Sciences
AVXL stock →Anavex Life Sciences Corp. operates as a biopharmaceutical company.
Healthcare · Biotechnology · 34 employees
About Eledon Pharmaceuticals
ELDN stock →Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company.
Healthcare · Biotechnology · 33 employees
AVXL vs ELDN FAQ
Which is bigger, Anavex Life Sciences or Eledon Pharmaceuticals?
Eledon Pharmaceuticals (ELDN) is larger, with a market capitalization of $173.09M compared with $121.43M for Anavex Life Sciences (AVXL).
Which stock has performed better over the past year, AVXL or ELDN?
ELDN returned -38.08% over the past 12 months, compared with -85.41% for AVXL (price return, excluding dividends). Past performance does not predict future results.
Are Anavex Life Sciences and Eledon Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.